New Tech Aims to Transform Opioid Treatment on the Front Lines

OAK BROOK, IL – April 07, 2026 – In a significant move to bolster the technological arsenal against the opioid crisis, Streamline Healthcare Solutions has launched SMARTdispense™, a new software module designed to unify the complex and often fragmented world of medication-assisted treatment (MAT). The new system, integrated within the company's established SmartCare™ electronic health record (EHR) platform, aims to bring efficiency, safety, and rigid compliance to the high-stakes environment of Opioid Treatment Programs (OTPs).

For years, clinics on the front lines of the opioid epidemic have grappled with disjointed systems, creating operational bottlenecks that can hinder patient care. The launch of SMARTdispense™ addresses this challenge directly, promising a seamless workflow for providers managing life-saving medications like methadone and buprenorphine.

Confronting a Fragmented System

Behind the doors of many OTPs, a daily battle with inefficiency unfolds. Clinicians and administrative staff often navigate a maze of disconnected software for patient check-ins, separate systems for controlling dispensing pumps, manual logs for inventory, and distinct platforms for billing and compliance reporting. This fragmentation creates information silos, increasing the risk of errors and consuming valuable staff time that could be dedicated to patient care.

Industry studies and reports have consistently pointed to this operational friction as a significant barrier to scaling up effective treatment. The reliance on manual processes for documentation and tracking every dose, drug test, and clinical interaction is not only time-consuming but also prone to human error. For organizations operating under the stringent oversight of the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA), maintaining audit-ready records across these disparate systems is a constant, resource-intensive challenge.

This fragmented landscape can directly impact patient safety. Without real-time, integrated data at the point of care, the risk of medication errors increases. The lack of a unified view of a patient's status can make it difficult to manage complex cases, such as dose adjustments or treatment holds, with the speed and accuracy required.

A Unified Approach to Medication-Assisted Treatment

Streamline Healthcare Solutions designed SMARTdispense™ to replace this patchwork of systems with a single, integrated experience. The module consolidates front-desk check-in, dosing workflows, dispensing pump integration, bottle- and lot-level inventory management, and audit-ready reporting directly within the SmartCare™ EHR.

This unified approach means that when a patient checks in, their entire profile—including treatment plan, recent toxicology results, and any clinical holds—is immediately available to the dispensing nurse on one screen. This integration is designed to streamline high-volume clinic operations while enforcing consistent clinical safeguards.

“Opioid treatment programs shouldn’t have to rely on fragmented systems to deliver critical care. With SMARTdispense™, we’re bringing dispensing, clinical safeguards, and compliance together in a single, integrated experience within SmartCare™,” said Navid Asgari, Chief Executive Officer of Streamline Healthcare Solutions, in the company's announcement. “This is about setting a higher standard. It gives providers the tools they need to operate more efficiently, reduce risk, and deliver better outcomes at scale.”

While other EHR providers offer solutions for MAT, Streamline is emphasizing this deep integration of clinical, medical, billing, and compliance processes as its key differentiator. The system supports a variety of real-world scenarios, including standard clinic dosing, managing take-home medication schedules, handling exceptions, and re-dispensing with a full audit trail, all while supporting industry-standard methadone dispensing pumps.

Bolstering Safety and Ensuring Compliance

A core component of the new module is its focus on enhancing patient safety and simplifying regulatory adherence. SMARTdispense™ introduces a layer of configurable controls and automated safeguards designed to reduce risk and standardize care delivery. These features include mandatory confirmations for doses that exceed a certain threshold, automated checks for required toxicology screenings before dispensing, and the ability for clinicians to place configurable holds on a client’s treatment for review.

The system's design directly addresses the complex web of regulations governing OTPs. It provides functionality for audit-ready documentation and reporting required by the DEA and other state and federal bodies. This is particularly relevant in light of SAMHSA's 2024 final rule, which updated federal regulations to increase access to MAT while maintaining strict standards. By embedding these compliance checks and reporting capabilities into the daily workflow, the software aims to reduce the administrative burden on providers and ensure they are perpetually prepared for audits.

Furthermore, the platform is built to handle the stringent privacy requirements of 42 CFR Part 2, which governs the confidentiality of substance use disorder patient records. By integrating dispensing into a behavioral health-specific EHR, it ensures that sensitive patient data is managed with the highest level of security and compliance. The system even includes downtime-ready workflows, ensuring that accurate records can be maintained if dispensing equipment or network connections become temporarily unavailable.

From Code to Clinic: Early Adoption and Broader Impact

SMARTdispense™ is not just a concept; it is already in use at several provider locations across the country, including the Tacoma-Pierce County Health Department in Washington, the Community Behavioral Health Clinic in Illinois, and Helio Health in New York. Helio Health, a large provider of mental health and substance use services, had previously selected Streamline's SmartCare™ platform in 2023 to unify its operations, signaling a strategic move toward integrated data and care coordination that the new module now enhances.

By streamlining the delivery of MAT—a treatment proven to decrease opioid-related mortality—such technology has the potential for a significant public health impact. More efficient clinic operations can lead to reduced wait times and the capacity to serve more patients, expanding access to care in communities that desperately need it. The enhanced safety features help protect patients and reduce the risk of diversion, while the robust data collection provides a clearer picture of treatment efficacy and population health trends.

Ultimately, the launch of SMARTdispense™ reflects a broader trend in healthcare: leveraging integrated technology not just for administrative efficiency, but as a critical tool for improving clinical outcomes and addressing major public health crises. By reducing friction and enhancing safety in the delivery of medication-assisted treatment, such innovations empower providers on the front lines to focus on their primary mission: helping individuals find a safer path to recovery.